Tag Archives: Paul Herrling

Will WHO Member States Pony Up for Neglected Diseases?

Recognizing that traditional market forces – namely incentives related to intellectual property and a steady demand for products – have failed in developing countries, the World Health Organization (WHO) asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest nations. [...]
Posted in Emerging Markets, Global, IP, Legal, Manufacturing, Market Access, R&D, leadership, pricing | Also tagged , , , , , , , , , | Leave a comment